Il-15 inhibitors useful for the treatment of atopic dermatitis
AssigneeNovartis Pharma AG
InventorsAlain VICARI, Yolande CHVATCHKO MISSOTTEN
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of agents able to neutralize the activity of interleukin-15 in the treatment of atopic dermatitis. In particular, the invention relates to IL-15 inhibitors for use in the prevention and/or treatment of atopic dermatitis.
Claims18
An interleukin-15 inhibitor for use in the treatment of atopic dermatitis.
A pharmaceutical composition comprising an interleukin-15 inhibitor and an agent useful in the prevention and/or treatment of atopic dermatitis and a pharmaceutically acceptable carrier, diluent or excipient thereof.
A method of preventing and/or treating atopic dermatitis in a subject, said method comprising administering in a subject in need thereof a therapeutically effective amount of an interleukin-15 inhibitor or pharmaceutical composition thereof.
Dependencies are inferred from the claim text.